{"url_path":"/sec/imnn/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/749647/0001493152-26-027201-index.html","accession_number":"0001493152-26-027201","cik":"0000749647","ticker":"IMNN","issuer_name":"Imunon, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/749647/0001493152-26-027201-index.html","primary_entity_key":"0000749647","primary_entity_name":"Imunon, Inc."},"word_count":177,"has_tables":true,"body_markdown":"**Item 9.01.****Financial\nStatements and Exhibits.**\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n3.1\n \n[Certificate of Designation of Preferences and Rights of Series A Preferred Stock.](ex3-1.htm)\n\n10.1*\n \n[Securities\nPurchase Agreement dated June 2, 2026, by and between the Company and Streeterville Capital, LLC.](ex10-1.htm)\n\n10.2\n \n[Secured\nPromissory Note A-1 dated June 2, 2026, made by the Company in favor of Streeterville Capital, LLC.](ex10-2.htm)\n\n10.3\n \n[Secured\nPromissory Note B dated June 2, 2026, made by the Company in favor of Streeterville Capital, LLC.](ex10-3.htm)\n\n99.1\n \n[Press Release dated June 4, 2026.](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded with the Inline XBRL document).\n\n \n\n*\nCertain schedules and exhibits to this Exhibit have been omitted. The Company agrees to furnish a copy of the omitted schedules and exhibits\nto the Securities and Exchange Commission on a supplemental basis upon its request.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**IMUNON,\nINC.**\n\n \n \n \n\n \nBy:\n*/s/\nJeffrey Church*\n\n \n \nJeffrey\nChurch\n\n \n \nChief\nFinancial Officer\n\n \n \n \n\nDate:\nJune 4, 2026"}